ENGMAB SARL has a total of 51 patent applications. It decreased the IP activity by 40.0%. Its first patent ever was published in 2014. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are IGM BIOSCIENCES INC, GENMAB BV and PANDION THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 7 | |
#2 | United States | 7 | |
#3 | Australia | 5 | |
#4 | Chile | 4 | |
#5 | Japan | 4 | |
#6 | Republic of Korea | 4 | |
#7 | Brazil | 2 | |
#8 | Canada | 2 | |
#9 | China | 2 | |
#10 | Israel | 2 | |
#11 | Mexico | 2 | |
#12 | Singapore | 2 | |
#13 | WIPO (World Intellectual Property Organization) | 2 | |
#14 | Colombia | 1 | |
#15 | EAPO (Eurasian Patent Organization) | 1 | |
#16 | Hong Kong | 1 | |
#17 | Hungary | 1 | |
#18 | Serbia | 1 | |
#19 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Peptides | |
#3 | Medical preparations | |
#4 | Analysing materials | |
#5 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Strein Klaus | 40 |
#2 | Vu Minh Diem | 38 |
#3 | Ast Oliver | 32 |
#4 | Klein Christian | 32 |
#5 | Moessner Ekkehard | 28 |
#6 | Moser Samuel | 28 |
#7 | Umana Pablo | 28 |
#8 | Bacac Marina | 25 |
#9 | Freimoser-Grundschober Anne | 23 |
#10 | Weinzierl Tina | 17 |
Publication | Filing date | Title |
---|---|---|
WO2020089437A1 | Combination therapy | |
BR112019008426A2 | bispecific antibody against bcma and cd3 and an immunological drug for combined use in the treatment of multiple myeloma |